Search Chat Visualize Browse

Hypothesis Results Question Article Posters Peer Review CV+

/Positive efficacy and favorable safety of barzolvolimab in chronic inducible urticaria: phase II trial results

Articles (10)

About Privacy Terms

Copyright © 2026. AllSci Corp. All rights reserved.